IceCure Successfully Completes First Cryoablation Treatment in Its ChoICE Post-Marketing Study for Breast Cancer Cryoablation
First patient enrolled and treated at West Cancer Center in Tennessee, USA CAESAREA, Israel, Oct. 27, 2026 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure," "IceCure Medical" or the "Company"), a developer of minimally-invasive cryoablation technology that destroys tumors by...
Covered in this story
Call it yourself
No calls on $POST yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Post Holdings →Dalsna Finance is currently tracking 13 stories mentioning Post Holdings, the earliest published 20 Jul 2026.
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.